Skip to main content

Table 3 Number and percentage of CIN2+ cases based on the biopsies according to cytology result and previous radiotherapy status read manually

From: Cervicovaginal cytology in patients undergoing pelvic radiotherapy using the Focalpoint system: results from the RODEO study

Cytology result

No previous radiotherapy

Previous radiotherapy

PR

95% CI (PR)

N (%)

N (%)

ASCUS + ASCH + AGC

34 (40.5)

6 (33.3)

0.8

0.4 – 1.7

LSIL

20 (37.0)

1 (25.0)

0.7

0.1 – 3.8

HSIL or worse

77 (74.8)

9 (60.0)

0.8

0.5 – 1.2

  1. PR = prevalence ratio (ratio of cytology abnormalities between the groups who did or did not receive previous radiotherapy).
  2. 95% CI = 95% confidence interval.